Plug Power Inc. (NASDAQ:PLUG) shares decreased -0.49% in last trading session and ended the day at $2.03. PLUG Gross Margin is -9.60% and its has a return on assets of -28.40%. Plug Power Inc. (NASDAQ:PLUG) quarterly performance is -3.79%.
Plug Power Inc. (NASDAQ:PLUG) announced it will exhibit and host a press conference at MODEX 2016, happening now through April 7, 2016 at the Georgia World Congress Center in Atlanta.
First Community Corporation (NASDAQ:FCCO) ended the last trading day at $14.45. Company weekly volatility is calculated as 1.24% and price to cash ratio as 3.92. First Community Corporation (NASDAQ:FCCO) showed a weekly performance of -1.97%.
Zacks Investment Research cut shares of First Community Corporation (NASDAQ:FCCO) from a buy rating to a hold rating in a report published on Wednesday,AnalystRatings.Net reports.
On 04 April, Pfizer Inc. (NYSE:PFE) shares increased 2.26% and was closed at $30.72. PFE EPS growth in last 5 year was 1.60%. Pfizer Inc. (NYSE:PFE) year to date (YTD) performance is -3.88%.
Pfizer Inc. (NYSE:PFE) announced that the Phase 3 SPIRE-AI (AutoInjector) trial of the investigational Proprotein Convertase Subtilisin Kexin type 9 inhibitor (PCSK9i) bococizumab administered with a pre-filled pen met its co-primary endpoints: percent change from baseline in low-density lipoprotein cholesterol (LDL-C) reduction at 12 weeks compared to placebo and proportion of patients successfully operating the pre-filled pen.
Biogen Inc. (NASDAQ:BIIB) shares increased 1.33% in last trading session and ended the day at $264.01. BIIB Gross Margin is 88.50% and its has a return on assets of 19.60%. Biogen Inc. (NASDAQ:BIIB) quarterly performance is -13.82%.
Biogen Inc. (NASDAQ:BIIB) announced the appointment of Michel Vounatsos as executive vice president and chief commercial officer, effective April 18, 2016.
OXiGENE, Inc. (NASDAQ:OXGN) caters to the Healthcare space. Its weekly performance is 2.64%. On the last day of trading company shares ended up at $0.74. OXiGENE, Inc. (NASDAQ:OXGN) distance from 50-day simple moving average (SMA50) is 3.38%.
On 30 March, OXiGENE, Inc. (NASDAQ:OXGN) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CA4P for the treatment of platinum-resistant ovarian cancer. Companies with Fast Track designation are able to benefit from more frequent meetings and communications with the FDA regarding development plans to support product registration, and may also be eligible for priority review of New Drug Applications, which shortens FDA’s standard review timeline.
Leave a Reply